Secukinumab for treating moderate to severe plaque psoriasis

Supporting evidence

• Review decision

• Review decision – September 2018

• Review decision paper  (PDF 561 KB)

  Published:

  19 September 2018

• Matrix of stakeholders (PDF 219 KB)

  Published:

  19 September 2018